Review paper

Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction

Volume: 18, Issue: 3, Pages: 181 - 193
Published: Feb 24, 2018
Abstract
Metformin is a biguanide that is widely used as an insulin-sparing agent to treat diabetes. When compared with the general population, diabetics are twice as likely to die from fatal myocardial infarction and congestive heart failure (CHF). There has been a significant concern regarding the use of metformin in patients with CHF because of their higher tendency to develop lactic acidosis. However, large epidemiological trials have reported better...
Paper Details
Title
Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
Published Date
Feb 24, 2018
Volume
18
Issue
3
Pages
181 - 193
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.